Indian startups raise Rs. 14,402 crore (US$ 1.65 billion) in February 2025, median valuation at Rs. 726 crore (US$ 83.2 million)
- IBEF
- March 4, 2025
Indian startups raised Rs. 14,402 crore (US$ 1.65 billion) in February 2025 at a median valuation of Rs. 726 crore (US$ 83.2 million), according to Traxcn. This brings the total FY25 (April-February) funding to Rs. 2,21,701 crore (US$ 25.4 billion) across 2,200 rounds. February saw a 19.5% increase from January’s Rs. 12,052 crore (US$ 1.38 billion) but remained 20% lower than February 2024’s Rs. 17,988 crore (US$ 2.06 billion). Bengaluru startups led the funding race with Rs. 3,081 crore (US$ 353 million). Mumbai startups secured Rs. 890 crore (US$ 102 million), though with a higher median round size of Rs. 44 crore (US$ 5 million). Fintech firm Oxyzo topped February’s funding chart with Rs. 87,290 crore (US$ 1 billion) in conventional debt, followed by udaan, which raised Rs. 6,547 crore (US$ 75 million) in Series G equity funding. Other major fundraisers included SpotDraft, Cashfree Payments, Zeta, and Geniemode.
February 2025 also saw major acquisitions, with Head Digital Works acquiring Deltatech Gaming for Rs. 491 crore (US$ 56.20 million) and Perfios acquiring fraud detection platform Clari5. Motilal Oswal Alternate Investment Advisors (MO Alts) acquired a majority stake in Megafine Pharma for Rs. 460 crore (US$ 52.70 million). A total of 16 Initial Public Offerings (IPOs) were listed, with a median IPO market capitalization of Rs. 2,313 crore (US$ 26.5 million), including Hexaware, AJAX, Ken India, Dr. Agarwal’s Eye Hospital, and Royal Arc. Investors Mr. Ritesh Agarwal, Mr. Anupam Mittal, Mr. Aman Gupta, and Mr. Peyush Bansal led the funding charts, along with venture capital (VC) firms Blume Ventures, Eximius Ventures, Unicorn India Ventures, Peak XV, Accel, and Nexus Venture Partners. In 2024, Indian startups raised Rs. 2,65,002 crore (US$ 30.4 billion), a 6.5% decline from Rs. 2,83,692 crore (US$ 32.5 billion) in 2023.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
Partners
